The close links between COVID-19 and air pollution, conclusions of the Council of the EU on air quality, the implications of the European Commission's Farm to Fork Strategy, the European Human Exposome Network and more updates on allergy and asthma health are covered in the second Interest Group newsletter of 2020.

The first 2020 edition of the Interest Group's "Allergy and Asthma Exchange" is now available. This issue introduces the renewed composition of the Interest Group and captures its first policy event of the new Parliamentary term, in addition to covering latest allergy and asthma health updates from Europe. 

The European Parliament Interest Group on Allergy and Asthma convened its first meeting of the 2019-2024 legislature on 20 November 2019, laying out the route to policy successes in Europe for allergy and asthma research, prevention and quality management.

Hosted by Members of the European Parliament (MEPs) Sirpa Pietikäinen and Cristian-Silviu Bușoi, leading Interest Group members, the meeting explored policy improvements to address two of the most prevalent chronic diseases, which affect one in three Europeans and represent an ever-growing burden on societies and healthcare systems.

You are cordially invited to the annual meeting of the Interest Group on Allergy and Asthma, the first one into the 9th legislative term.

The event will discuss a new direction for allergy and asthma health in Europe, through thematic sessions looking at action across key policy areas.

The second edition of the Interest Group's "Allergy and Asthma Exchange" is now available. This issue captures latest activities of the Interest Group including a policy event in the European Parliament in March and the launch of the Interest Group's Blueprint, as well as news from the European Medicines Agency, the World Health Organisation and many more from across Europe. 

Air pollution is a public health emergency killing 391,000 people in the EU and being responsible for the onset and worsened symptoms of many chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD) or eczema.

The European Medicines Agency has launched a consultation that will serve to revise the European Commission Guideline Annex on the ‘Excipients in the labelling and package leaflet of medicinal products for human use’.

The European Commission Directorate-General for Health and Food Safety (DG SANTE) has asked the Scientific Committees on Health, Environmental and Emerging Risks (SCHEER) to provide their scientific input on e-cigarettes. 

Late January, the UK Department for Environment, Food and Rural Affairs legislative released a legislative proposal providing that labelling of ingredients is required on all food prepared on the premises in which it is sold.


On the 20th of March 2019, the European Parliament Interest Group on Allergy and Asthma launched a ‘blueprint’ to encourage the future Parliament to adopt a renewed EU policy agenda on allergy and airways diseases